Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep:105:86-98.
doi: 10.1016/j.neurobiolaging.2021.04.003. Epub 2021 Apr 22.

Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females

Affiliations
Free PMC article

Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females

Lauren Edwards et al. Neurobiol Aging. 2021 Sep.
Free PMC article

Abstract

We assessed sex differences in amyloid- and tau-PET retention in 119 amyloid positive patients with mild cognitive impairment or Alzheimer's disease (AD) dementia. Patients underwent 3T-MRI, 11C-PIB amyloid-PET and 18F-Flortaucipir tau-PET. Linear ordinary least squares regression models tested sex differences in Flortaucipir-PET SUVR in a summary temporal region of interest as well as global PIB-PET. No sex differences were observed in demographics, Clinical Dementia Rating Sum of Boxes (CDR-SoB), Mini-Mental State Exam (MMSE), raw episodic memory scores, or cortical thickness. Females had higher global PIB SUVR (ηp²=.043, p=.025) and temporal Flortaucipir SUVR (ηp²=.070, p=.004), adjusting for age and CDR-SoB. Sex differences in temporal Flortaucipir-PET remained significant when controlling additionally for PIB SUVR and APOE4 status (ηp²=.055, p=.013), or when using partial volume-corrected data. No sex differences were present in areas of known Flortaucipir off-target binding. Overall, females demonstrated greater AD regional tau-PET burden than males despite clinical comparability. Further characterization of sex differences will provide insight into AD pathogenesis and support development of personalized therapeutic strategies.

Keywords: Alzheimer's disease; Amyloid; Apolipoprotein E; Positron emission tomography; Sex differences; Tau.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Sex-stratified box plots of (A) global PIB PET, (B) temporal meta-ROI FTP PET, (C) individual AD ROI FTP PET, and (D) regions off-target FTP binding. Partial η2 and p-values of Model 1 group sex differences are reported.
Figure 2.
Figure 2.
Sex difference in temporal meta-ROI tau PET signal as a function of global amyloid PET signal. All global PIB SUVRs exceeded a value of 1.21 and are therefore in the amyloid-positive range, per study design (Villeneuve et al., 2015). For a given level of amyloid, female AD patients demonstrated greater temporal FTP SUVR than males per Model 2 analysis (ηp2 = .058, p = .009) as described in Table 3. The effect of amyloid on temporal meta-ROI tau PET was not significant (ηp2 = .012, p = .24), and when added to the model, no interaction between sex and global amyloid PET was observed (ηp2 =.004, p =.52).

Similar articles

Cited by

References

    1. 2020. Alzheimer’s disease facts and figures, 2020. Alzheimers Dement. 16, 391–460. 10.1002/alz.12068 - DOI
    1. Alber J, Alladi S, Bae H-J, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH, 2019. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimers Dement. Transl. Res. Clin. Interv. 5, 107–117. 10.1016/j.trci.2019.02.001 - DOI - PMC - PubMed
    1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH, 2011. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
    1. Altmann A, Tian L, Henderson VW, Greicius MD, 2014. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann. Neurol. 75, 563–573. 10.1002/ana.24135 - DOI - PMC - PubMed
    1. Armstrong NM, Huang C-W, Williams OA, Bilgel M, An Y, Doshi J, Erus G, Davatzikos C, Wong DF, Ferrucci L, Resnick SM, 2019. Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults. NeuroImage Clin. 22, 101769. 10.1016/j.nicl.2019.101769 - DOI - PMC - PubMed

Publication types